News & Media
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
BillionToOne is recognized by Forbes as one of America's Best Startup Employers for 2024!
BillionToOne is recognized by Forbes as one of America's Best Startup Employers for 2024!
BILLIONTOONE ANNOUNCES ROSS TAYLOR AS CHIEF FINANCIAL OFFICER
BILLIONTOONE ANNOUNCES ROSS TAYLOR AS CHIEF FINANCIAL OFFICER
BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn
BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn
UNITY Fetal Risk Screen has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.
UNITY Fetal Risk Screen has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.
BillionToOne recognized as one of the most promising digital health companies of 2023 by CB Insights
BillionToOne recognized as one of the most promising digital health companies of 2023 by CB Insights
Social Posts